4.6 Article

Synthesis, crystal structure investigation, Hirshfeld and DFT studies of newly synthesized dihydroisoquinoline derivatives

Journal

ARABIAN JOURNAL OF CHEMISTRY
Volume 16, Issue 11, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.arabjc.2023.105294

Keywords

Dihydroisoquinoline; Crystal structure; NBO; NLO; Molecular docking; ADMET; Dihydroisoquinoline; Crystal structure; NBO; NLO; Molecular docking; ADMET

Ask authors/readers for more resources

This study discovered the structures of new dihydroisoquinoline molecules and validated their interaction energy and optical characteristics. Molecular docking simulation and ADMET evaluations were also conducted to assess their therapeutic potential.
Isoquinoline and its derivatives, which constitute an important category of heterocyclic compounds and are found in a variety of naturally occurring alkaloids, serve a variety of biological purposes such as a potent agonist for human melatonin receptors 1. This research was conducted in an attempt to develop new dihydroisoquinoline molecules (III and IV). Single-crystal X-ray crystallography study validated their structures. The Hirshfeld surface analysis identifies intermolecular interactions by using a 2-D fingerprint map to recognize each type's relative contribution H center dot center dot center dot H connections are discovered to be dominating. The interaction energies between chemical pairs in crystal structures were found using an energy framework analysis. The DFT investigation demonstrates the electronic stability and reactivity of the compounds using the HOMO-LUMO and global reactivity descriptors, indicating that IV has higher chemical reactivity than III. The derived polarizability (ao) and hyperpolarizability (bo) values were used to calculate the optical and nonlinear optical characteristics of III and IV. The IV's significant bo value (488.94 au) indicates that it has good optical and NLO qualities. Molecular docking simulation using human melatonin receptors 1 was used to better understand the binding interaction mechanism of the title compounds. In addition, ADMET evaluations were performed to establish the therapeutic potential of III and IV.(c) 2023 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available